Ultragenyx Pharmaceutical | Stammkapital

Aktienkurs
24.70
Täglich Wechseln
0.91 3.83%
Monatlich
2.07%
Jährlich
-45.53%
Q1 Prognose
23.94




Stammkapital Veränderung Datum
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Insmed USD 212.58M 210.76M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Kyowa Hakko Kirin JPY 523.49M 0 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Ultragenyx Pharmaceutical Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.